4K
AstraZeneca announced a planned investment of $50 billion in the United States by 2030, aimed at expanding its manufacturing and research and development activities. The investment supports the company's goal of reaching $80 billion in revenue by 2030, with half of that total expected to be generated in the U.S.
AstraZeneca announced a planned investment of $50 billion in the United States by 2030, aimed at expanding its manufacturing and research and development activities. The investment supports the company's goal of reaching $80 billion in revenue by 2030, with half of that total expected to be generated in the U.S.
Contact your sales representative for commercial and promotional uses.